SS
Scott Schlackman
Director

Scott Schlackman insider trades: Medifast (MED) stock buys and sales

Director, Medifast Last trade May 11, 2026 25 Form 4 filings
$0
Sold, last 12 months
0 sales
$63K
Bought, last 12 months
1 buy
12
Open-market trades
since 2019
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Scott reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 11, 2026MED↑ Buy$63K
Mar 8, 2024MED↓ Sell$160K
Nov 7, 2023MED↑ Buy$4K
Aug 8, 2023MED↑ Buy$4K
May 9, 2023MED↑ Buy$1K
Mar 10, 2023MED↓ Sell$239K
Feb 7, 2023MED↑ Buy$1K
Nov 8, 2022MED↑ Buy$1K
May 19, 2021MED↓ Sell$310K
Jun 4, 2020MED↓ Sell$335K
Mar 8, 2019MED↓ Sell$262K
Mar 5, 2019MED↓ Sell$325K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MED insiders

Open-market trades in the last 12 months

About Scott Schlackman's insider trades

Scott Schlackman is a director at Medifast (MED). Since Mar 5, 2019, Scott has reported 6 open-market purchases worth $74K and 6 sales worth $1.6M on SEC Form 4. In the last 12 months: 1 buy ($63K).

Their filings also include grants and awards (13 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.